Publisher Summary This chapter describes the incidence, survival, recurrence,
complications, and risk factors for deep vein thrombosis of the leg, pelvis, or arm, and its …

The incidence of venous thromboembolism exceeds 1 per 1000; over 200,000 new cases
occur in the United States annually. Of these, 30% die within 30 days; one-fifth suffer sudden …

Venous thromboembolism is a major health problem, with an incidence that exceeds 1 per
1000. Over 200,000 new cases occur in the United States annually. Of these, 30% of …

The annual incidence of diagnosed venous thromboembolism (VTE) is 1 to 2 events per
1000 of the general population. VTE is very uncommon before age 20 years and, after 40 …

The epidemiology of venous thromboembolism (VTE) in the community has important
implications for VTE prevention and management. This review describes the disease burden …

Venous thrombosis, including deep vein thrombosis (DVT) and pulmonary embolism (PE),
occurs at an annual incidence of about 1 per 1,000 adults. Rates increase sharply after …

While there have been advances in prophylaxis and management of venous
thromboembolism (VTE), there are a dearth of data from the perspective of a community …

Thrombosis can affect any venous circulation. Venous thromboembolism (VTE) includes
deep-vein thrombosis of the leg or pelvis, and its complication, pulmonary embolism. VTE is …

Venous thromboembolism (VTE) is categorized by the US Surgeon General as a major
public health problem. VTE is relatively common and associated with reduced survival and …

Venous thromboembolism (VTE), defined as deep vein thrombosis, pulmonary embolism, or
both, affects an estimated 300,000–600,000 individuals in the US each year, causing …